- Home
- QGEN vs HSIC Comparison
QGEN vs HSIC Comparison
Compare QGEN & HSIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | QGEN | HSIC |
|---|---|---|
| Founded | 1986 | 1932 |
| Country | Netherlands | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Medical Specialities |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.2B | 8.8B |
| IPO Year | 1996 | 1995 |
Fundamental Metrics
Financial Performance| Metric | QGEN | HSIC |
|---|---|---|
| Price | $45.06 | $76.46 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 7 | 14 |
| Target Price | $49.74 | ★ $76.50 |
| AVG Volume (30 Days) | ★ 1.2M | 1.2M |
| Earning Date | 11-04-2025 | 11-04-2025 |
| Dividend Yield | ★ 3.34% | N/A |
| EPS Growth | ★ 331.20 | 30.70 |
| EPS | 1.84 | ★ 3.17 |
| Revenue | $2,070,781,000.00 | ★ $12,938,000,000.00 |
| Revenue This Year | $7.12 | $5.35 |
| Revenue Next Year | $6.13 | $3.34 |
| P/E Ratio | $24.59 | ★ $24.16 |
| Revenue Growth | ★ 5.32 | 3.51 |
| 52 Week Low | $37.63 | $60.56 |
| 52 Week High | $51.88 | $82.49 |
Technical Indicators
Market Signals| Indicator | QGEN | HSIC |
|---|---|---|
| Relative Strength Index (RSI) | 42.22 | 66.60 |
| Support Level | $45.55 | $71.27 |
| Resistance Level | $47.48 | $77.46 |
| Average True Range (ATR) | 0.59 | 1.48 |
| MACD | -0.17 | 0.07 |
| Stochastic Oscillator | 11.63 | 85.14 |
Price Performance
Historical ComparisonAbout QGEN Qiagen N.V.
Qiagen offers proprietary sample and assay technology to extract, purify, amplify, and interpret DNA, RNA, and proteins. The company's sales are split almost evenly between applications in life sciences and molecular diagnostics. Qiagen generates nearly 90% of its revenue from consumables with the balance coming from instrumentation and related services. The Americas account for the largest portion of the firm's revenue (52% of 2024 sales), followed by EMEA (33%), and the Asia-Pacific (15%).
About HSIC Henry Schein Inc.
Henry Schein Inc is a solutions company for healthcare professionals powered by a network of people and technology. The company is a provider of healthcare products and services to office-based dental and medical practitioners, as well as alternate sites of care. The company's reportable segments are Global Distribution and Value-Added Services; Global Specialty Products; and Global Technology. It generates the majority of its revenue from the Global Distribution and Value-Added Services segment, which includes distribution to the dental and medical markets of national brand and corporate brand merchandise, as well as equipment and related technical services.